---
figid: PMC3632399__nihms444003f3
figlink: /pmc/articles/PMC3632399/figure/F3/
number: F3
caption: Oncogenic RAS may have both pro-apoptotic and anti-apoptotic functions depending
  on the status of RAS effector pathways and the apoptotic machinery. In many cases
  oncogenic RAS signalling through the RAF pathway engages an apoptotic response that
  is mediated by p53. Also, signalling through the RAS effectors RASSF1, NORE1, mammalian
  STE20-like protein kinase 1 (MST1) and JUN N-terminal kinase (JNK) can lead to apoptotic
  death via the activation of caspase 3 and the pro-apoptotic proteins BCL-2-associated
  X protein (BAX) and BCL-2-homologous antagonist/killer 1 (BAK1). Acquisition of
  a tumorigenic phenotype is marked by the suppression of such mediators of RAS-induced
  apoptosis. In this context, the anti-apoptotic activity of RAS takes a stronghold.
  The anti-apoptotic function of oncogenic RAS is mediated by several effector pathways,
  including the RAS–PI3K effector pathway, which regulates the levels of pro-apoptotic
  protein BAK1 and inhibitors of apoptosis (IAPs), and the RAS–RAF pathway, which
  downregulates the pro-apoptotic transcriptional repressor prostate apoptosis response
  4 (PAR4) while upregulating the anti-apoptotic proteins BCL-2 and apoptosis repressor
  with caspase recruitment domain (ARC). Both pathways have been implicated in phosphorylating
  and inactivating the pro-apoptotic protein BCL-2-associated agonist of cell death
  (BAD). The mechanism through which RAS induces the epigenetic silencing of the pro-apoptotic
  CD95 gene remains to be uncovered. The asterisk represents the mutational activation
  of RAS protein. P, phosphorylation.
pmcid: PMC3632399
papertitle: 'RAS oncogenes: weaving a tumorigenic web.'
reftext: Yuliya Pylayeva-Gupta, et al. Nat Rev Cancer. ;11(11):761-774.
pmc_ranked_result_index: '27276'
pathway_score: 0.9641389
filename: nihms444003f3.jpg
figtitle: 'RAS oncogenes: weaving a tumorigenic web'
year: ''
organisms:
- Homo sapiens
ndex: 0cb3b884-ded0-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3632399__nihms444003f3.html
  '@type': Dataset
  description: Oncogenic RAS may have both pro-apoptotic and anti-apoptotic functions
    depending on the status of RAS effector pathways and the apoptotic machinery.
    In many cases oncogenic RAS signalling through the RAF pathway engages an apoptotic
    response that is mediated by p53. Also, signalling through the RAS effectors RASSF1,
    NORE1, mammalian STE20-like protein kinase 1 (MST1) and JUN N-terminal kinase
    (JNK) can lead to apoptotic death via the activation of caspase 3 and the pro-apoptotic
    proteins BCL-2-associated X protein (BAX) and BCL-2-homologous antagonist/killer
    1 (BAK1). Acquisition of a tumorigenic phenotype is marked by the suppression
    of such mediators of RAS-induced apoptosis. In this context, the anti-apoptotic
    activity of RAS takes a stronghold. The anti-apoptotic function of oncogenic RAS
    is mediated by several effector pathways, including the RAS–PI3K effector pathway,
    which regulates the levels of pro-apoptotic protein BAK1 and inhibitors of apoptosis
    (IAPs), and the RAS–RAF pathway, which downregulates the pro-apoptotic transcriptional
    repressor prostate apoptosis response 4 (PAR4) while upregulating the anti-apoptotic
    proteins BCL-2 and apoptosis repressor with caspase recruitment domain (ARC).
    Both pathways have been implicated in phosphorylating and inactivating the pro-apoptotic
    protein BCL-2-associated agonist of cell death (BAD). The mechanism through which
    RAS induces the epigenetic silencing of the pro-apoptotic CD95 gene remains to
    be uncovered. The asterisk represents the mutational activation of RAS protein.
    P, phosphorylation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP14
  - CASP2
  - BCR
  - CASP12
  - MAPK9
  - PIK3CD
  - CASP3
  - PIK3R6
  - BAD
  - CASP9
  - MAPK10
  - CASP7
  - MAPK8
  - PIK3R5
  - PIK3R4
  - HRAS
  - PIK3R3
  - CASP8
  - NRAS
  - CASP4
  - BAK1
  - PIK3CG
  - CASP1
  - KRAS
  - PIK3CA
  - CASP5
  - BRAF
  - RAF1
  - CASP6
  - ARAF
  - PIK3CB
  - CASP10
  - Cancer
genes:
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: All
  symbol: ALL
  source: hgnc_alias_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: RAS*
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: RAS*
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: BAK
  symbol: BAK
  source: hgnc_alias_symbol
  hgnc_symbol: BAK1
  entrez: '578'
- word: •BAK1↑
  symbol: BAK1
  source: hgnc_symbol
  hgnc_symbol: BAK1
  entrez: '578'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: RAS*
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3632399__F3
redirect_from: /figures/PMC3632399__F3
figtype: Figure
---
